Clinical Trial Update: The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the use of umbilical cord mesenchymal stem cells for amyotrophic lateral sclerosis; the trial status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: General Hospital of Chinese Armed Police Forces | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: UNKNOWN